• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇晶体在健康和疾病中的形成及细胞影响。

Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.

机构信息

Social Determinants of Obesity and Cardiovascular Risk Laboratory, National Heart, Lung, and Blood Institute, Building 10, 10 Center Drive, Bethesda, MD, 20814, USA.

Dept. of Medicine, University of California San Diego, 9500 Gilman Street, La Jolla, CA, 92093, USA.

出版信息

Adv Biol (Weinh). 2021 Nov;5(11):e2100638. doi: 10.1002/adbi.202100638. Epub 2021 Sep 29.

DOI:10.1002/adbi.202100638
PMID:34590446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11055929/
Abstract

Cholesterol crystals (CCs) were first discovered in atherosclerotic plaque tissue in the early 1900 and have since been observed and implicated in many diseases and conditions, including myocardial infarction, abdominal aortic aneurism, kidney disease, ocular diseases, and even central nervous system anomalies. Despite the widespread involvement of CCs in many pathologies, the mechanisms involved in their formation and their role in various diseases are still not fully understood. Current knowledge concerning the formation of CCs, as well as the molecular pathways activated upon cellular exposure to CCs, will be explored in this review. As CC formation is tightly associated with lipid metabolism, the role of cellular lipid homeostasis in the formation of CCs is highlighted, including the role of lysosomes. In addition, cellular pathways and processes known to be affected by CCs are described. In particular, CC-induced activation of the inflammasome and production of reactive oxygen species, along with the role of CCs in complement-mediated inflammation is discussed. Moreover, the clinical manifestation of embolized CCs is described with a focus on renal and skin diseases associated with CC embolism. Lastly, potential therapeutic measures that target either the formation of CCs or their impact on different cell types and tissues are highlighted.

摘要

胆固醇晶体(CCs)于 20 世纪初首次在动脉粥样硬化斑块组织中被发现,此后在许多疾病和病症中均有观察到 CCs 的存在并认为其与这些疾病相关,包括心肌梗死、腹主动脉瘤、肾脏疾病、眼部疾病,甚至中枢神经系统异常。尽管 CCs 广泛参与了许多病理学过程,但它们的形成机制及其在各种疾病中的作用仍未完全阐明。本综述将探讨 CC 形成的相关知识,以及细胞暴露于 CCs 后激活的分子途径。由于 CC 的形成与脂质代谢密切相关,因此强调了细胞脂质稳态在 CC 形成中的作用,包括溶酶体的作用。此外,还描述了已知受 CC 影响的细胞途径和过程。特别地,讨论了 CC 诱导的炎症小体激活和活性氧的产生,以及 CC 在补体介导的炎症中的作用。此外,还描述了栓塞的 CC 引发的临床表现,重点是与 CC 栓塞相关的肾脏和皮肤疾病。最后,强调了针对 CC 形成或其对不同细胞类型和组织的影响的潜在治疗措施。

相似文献

1
Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.胆固醇晶体在健康和疾病中的形成及细胞影响。
Adv Biol (Weinh). 2021 Nov;5(11):e2100638. doi: 10.1002/adbi.202100638. Epub 2021 Sep 29.
2
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.从晶体透镜看动脉粥样硬化:动脉粥样硬化斑块中胆固醇晶体结构的演变如何改变其稳定性。
J Clin Lipidol. 2020 Sep-Oct;14(5):619-630. doi: 10.1016/j.jacl.2020.07.003. Epub 2020 Jul 11.
3
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.胆固醇结晶利用补体增加冠状动脉和颈动脉粥样硬化中的 NLRP3 信号通路。
EBioMedicine. 2020 Oct;60:102985. doi: 10.1016/j.ebiom.2020.102985. Epub 2020 Sep 11.
4
Cholesterol-embolization syndrome: current perspectives.胆固醇栓塞综合征:当前观点
Vasc Health Risk Manag. 2019 Jul 8;15:209-220. doi: 10.2147/VHRM.S175150. eCollection 2019.
5
Activation of NLRP3 inflammasome by cholesterol crystals in alcohol consumption induces atherosclerotic lesions.胆固醇晶体在酒精摄入中激活 NLRP3 炎性体,诱导动脉粥样硬化病变。
Brain Behav Immun. 2017 May;62:291-305. doi: 10.1016/j.bbi.2017.02.014. Epub 2017 Feb 21.
6
Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.胆固醇晶体与动脉粥样硬化斑块不稳定性:二十碳五烯酸的治疗潜力。
Pharmacol Ther. 2022 Dec;240:108237. doi: 10.1016/j.pharmthera.2022.108237. Epub 2022 Jun 27.
7
Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.环糊精通过调节补体激活减轻胆固醇晶体诱导的炎症。
J Immunol. 2017 Oct 15;199(8):2910-2920. doi: 10.4049/jimmunol.1700302. Epub 2017 Aug 30.
8
Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals.杀死罪魁祸首:用药物消除胆固醇结晶。
Curr Probl Cardiol. 2022 Sep;47(9):101274. doi: 10.1016/j.cpcardiol.2022.101274. Epub 2022 Jun 2.
9
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.胆固醇结晶诱导补体依赖性炎性体激活和细胞因子释放。
J Immunol. 2014 Mar 15;192(6):2837-45. doi: 10.4049/jimmunol.1302484. Epub 2014 Feb 19.
10
Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.磷脂纳米粒:通过减少胆固醇晶体和抑制炎症来对抗动脉粥样硬化的治疗潜力。
EBioMedicine. 2021 Dec;74:103725. doi: 10.1016/j.ebiom.2021.103725. Epub 2021 Dec 6.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol Synthesis and Impaired Synthesis/Absorption Balance.代谢功能障碍相关脂肪性肝病的特征是内源性胆固醇合成增强以及合成/吸收平衡受损。
Int J Mol Sci. 2025 Aug 1;26(15):7462. doi: 10.3390/ijms26157462.
2
Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis.靶向胆固醇驱动的细胞焦亡:一种防治动脉粥样硬化的有前景策略。
Mol Biol Rep. 2025 May 15;52(1):459. doi: 10.1007/s11033-025-10554-8.
3
Gallstones in the Era of Metabolic Syndrome: Pathophysiology, Risk Prediction, and Management.

本文引用的文献

1
Vascular imaging of atherosclerosis: Strengths and weaknesses.动脉粥样硬化的血管成像:优势与不足。
Atherosclerosis. 2021 Feb;319:42-50. doi: 10.1016/j.atherosclerosis.2020.12.021. Epub 2021 Jan 6.
2
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.胆固醇结晶利用补体增加冠状动脉和颈动脉粥样硬化中的 NLRP3 信号通路。
EBioMedicine. 2020 Oct;60:102985. doi: 10.1016/j.ebiom.2020.102985. Epub 2020 Sep 11.
3
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
代谢综合征时代的胆结石:病理生理学、风险预测与管理
Cureus. 2025 Mar 13;17(3):e80541. doi: 10.7759/cureus.80541. eCollection 2025 Mar.
4
Long-term clinical significance of the presence of puff-chandelier ruptures detected by non-obstructive aortic angioscopy.非阻塞性主动脉血管镜检查发现的“泡芙-吊灯”样破裂的长期临床意义。
Sci Rep. 2025 Mar 12;15(1):8530. doi: 10.1038/s41598-025-92062-0.
5
Association of PTX3 Genetic Variants With Development of Diabetic Neuropathy.PTX3基因变异与糖尿病神经病变发生的关联
In Vivo. 2025 Mar-Apr;39(2):702-712. doi: 10.21873/invivo.13874.
6
Unusual cholesterol crystal formation in a rare clinical case report of splenic echinococcal cyst in a patient from Sardinia, Italy.意大利撒丁岛一名患者脾脏棘球蚴囊肿罕见临床病例报告中的异常胆固醇晶体形成。
Front Parasitol. 2025 Jan 10;3:1498099. doi: 10.3389/fpara.2024.1498099. eCollection 2024.
7
Association between atherosclerosis and the development of multi-organ pathologies.动脉粥样硬化与多器官病变发展之间的关联。
SAGE Open Med. 2024 Dec 23;12:20503121241310013. doi: 10.1177/20503121241310013. eCollection 2024.
8
Lipidomic Profiling of Kidney Cortical Tubule Segments Identifies Lipotypes with Physiological Implications.肾脏皮质小管段的脂质组学分析确定了具有生理意义的脂质亚型。
Function (Oxf). 2024 Jul 11;5(4). doi: 10.1093/function/zqae016.
从晶体透镜看动脉粥样硬化:动脉粥样硬化斑块中胆固醇晶体结构的演变如何改变其稳定性。
J Clin Lipidol. 2020 Sep-Oct;14(5):619-630. doi: 10.1016/j.jacl.2020.07.003. Epub 2020 Jul 11.
4
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病:从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.
5
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine.LDL 胆固醇从溶酶体到质膜再到内质网的路径中的最后一步受磷脂酰丝氨酸控制。
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18521-18529. doi: 10.1073/pnas.2010682117. Epub 2020 Jul 20.
6
Hyperlipidaemia and IFNgamma/TNFalpha Synergism are associated with cholesterol crystal formation in Endothelial cells partly through modulation of Lysosomal pH and Cholesterol homeostasis.高脂血症和 IFNgamma/TNFalpha 协同作用与内皮细胞中胆固醇晶体的形成有关,部分是通过调节溶酶体 pH 和胆固醇稳态。
EBioMedicine. 2020 Sep;59:102876. doi: 10.1016/j.ebiom.2020.102876. Epub 2020 Jul 6.
7
Cyclodextrins: Potential therapeutics against atherosclerosis.环糊精:抗动脉粥样硬化的潜在治疗药物。
Pharmacol Ther. 2020 Oct;214:107620. doi: 10.1016/j.pharmthera.2020.107620. Epub 2020 Jun 26.
8
Cholesterol crystals and atherosclerosis.胆固醇结晶与动脉粥样硬化。
Eur Heart J. 2020 Jun 21;41(24):2236-2239. doi: 10.1093/eurheartj/ehaa505.
9
Imaging of the vulnerable carotid plaque: Role of imaging techniques and a research agenda.易损颈动脉斑块的影像学检查:影像学技术的作用及研究议程
Neurology. 2020 May 26;94(21):922-932. doi: 10.1212/WNL.0000000000009480. Epub 2020 May 11.
10
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.